340B Drug Pricing Program

Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
AHA, co-plaintiffs urge court to block 340B rebate model that would divert resources from patient care.
The AHA and its co-plaintiffs Nov. 16 filed a reply brief urging a federal court to block implementation of the Health Resources and Services Administration’s 340B rebate model before its Jan. 1, 2027, effective date.
AHA releases summaries of outpatient PPS and physician fee schedule rules that have 340B provisions.
CMS’ Medicare outpatient hospital payment rate does not adequately take into account the financial challenges facing hospitals today. These challenges are amplified for hospitals serving rural and underserved communities, many of which are already making hard decisions about how they will maintain…
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act).
The AHA yesterday submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act).
The SUSTAIN 340B Act represents a constructive bipartisan effort to establish clear and durable rules for all stakeholders in the program.
Please encourage your House representatives to co-sponsor the 340B Rebate Model Delay Act (H.R. 10770), a bipartisan bill that would pause the Department of Health and Human Services 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.